Tuesday, February 20, 2018 10:15 PM ET
Insider Makes Significant Stock buy in La Jolla Pharmaceutical Co (LJPC) Shares Extends the Trend of Last 90 Days
An insider — Perceptive Advisors Llc, 10% Owner — acquired 50,000 shares of La Jolla Pharmaceutical Co having a market value of approximately $1,621,000 today, as revealed in a form 4 document filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been buys resulting in the purchase of 176,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net purchases of 226,000 shares and have averaged 75,333 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at La Jolla Pharmaceutical Co is higher than its 281-company peer group average. The Bio Therapeutic Drugs peer group saw 318 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by La Jolla Pharmaceutical Co insiders is lower than its peers. Within the peer group there were 25,809,865 shares purchased and 34,482,876 shares sold with company insiders having sold 27,274 shares on average over this time period.
To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data obtained to create and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.